Stock Events

Stock Events

NeuroSense Therapeutics (NRSN) Q1 2026 Earnings

31MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.24

-0.17

-0.11

-0.04

Details

Expected EPS

-0.0708

Actual EPS

-0.235

Surprise EPS

-0.16

Surprise Percent

+231.92%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.235 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.